PURE Bioscience Overview
Latest PEG ratio for PURE Bioscience: -40.15 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-40.15
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for PURE is -40.15. That is below the sector sector average of -7.59. Investors often review this figure alongside PURE Bioscience's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, PURE currently prints -40.15 for PEG ratio, while the sector average sits near -7.59. That is roughly 428.9% below the sector mean. Large gaps often invite a closer look at PURE Bioscience's growth, margins, and balance sheet.
A PEG ratio of -40.15 for PURE Bioscience is not 'good' or 'bad' on its own. Compare it with the peer average (-7.59) and with PURE's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PURE's PEG ratio (-40.15), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
